1. Home
  2. SRRK vs KAI Comparison

SRRK vs KAI Comparison

Compare SRRK & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • KAI
  • Stock Information
  • Founded
  • SRRK 2012
  • KAI 1991
  • Country
  • SRRK United States
  • KAI United States
  • Employees
  • SRRK N/A
  • KAI N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • KAI Industrial Machinery/Components
  • Sector
  • SRRK Health Care
  • KAI Industrials
  • Exchange
  • SRRK Nasdaq
  • KAI Nasdaq
  • Market Cap
  • SRRK 3.0B
  • KAI 3.6B
  • IPO Year
  • SRRK 2018
  • KAI N/A
  • Fundamental
  • Price
  • SRRK $29.66
  • KAI $290.89
  • Analyst Decision
  • SRRK Strong Buy
  • KAI Buy
  • Analyst Count
  • SRRK 9
  • KAI 2
  • Target Price
  • SRRK $47.88
  • KAI $340.00
  • AVG Volume (30 Days)
  • SRRK 3.2M
  • KAI 131.5K
  • Earning Date
  • SRRK 11-14-2025
  • KAI 10-28-2025
  • Dividend Yield
  • SRRK N/A
  • KAI 0.47%
  • EPS Growth
  • SRRK N/A
  • KAI N/A
  • EPS
  • SRRK N/A
  • KAI 8.98
  • Revenue
  • SRRK N/A
  • KAI $1,024,121,000.00
  • Revenue This Year
  • SRRK N/A
  • KAI N/A
  • Revenue Next Year
  • SRRK $1,911.27
  • KAI $5.10
  • P/E Ratio
  • SRRK N/A
  • KAI $32.41
  • Revenue Growth
  • SRRK N/A
  • KAI 1.74
  • 52 Week Low
  • SRRK $22.71
  • KAI $270.73
  • 52 Week High
  • SRRK $46.98
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 40.62
  • KAI 42.86
  • Support Level
  • SRRK $29.00
  • KAI $272.34
  • Resistance Level
  • SRRK $29.35
  • KAI $310.71
  • Average True Range (ATR)
  • SRRK 2.50
  • KAI 10.26
  • MACD
  • SRRK -0.81
  • KAI 1.20
  • Stochastic Oscillator
  • SRRK 12.63
  • KAI 48.34

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: